home / stock / wald / wald news


WALD News and Press, Waldencast plc

Stock Information

Company Name: Waldencast plc
Stock Symbol: WALD
Market: NASDAQ
Website: waldencast.com

Menu

Get WALD Alerts

News, Short Squeeze, Breakout and More Instantly...

WALD - Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ(TM) Injectable Hyaluronic Acid Gel

LONDON, June 15, 2026 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that the U.S. Food and Drug Administration (“FDA”) has approved Obagi ® sayph...

WALD - Waldencast to sell Obagi Medical for $460M

2026-06-01 14:45:40 ET More on Waldencast Seeking Alpha’s Quant Rating on Waldencast Historical earnings data for Waldencast Financial information for Waldencast Read the full article on Seeking Alpha For further details see: Waldencast to ...

WALD - Waldencast Announces Sale of Obagi Medical to Bridgepoint

LONDON, June 01, 2026 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or “the Company”) today announced that it has entered into a definitive agreement to sell its Obagi Medical dermatological skincare and aesthetics business (“Obagi Medical ...

WALD - Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting

NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD), today announced new data shared at the Music City SCALE meeting taking place May 13-17 in Nashville, TN. Results from...

WALD - Obagi and Next Health Partner to Launch "The Skin Recharge Station" Pop-Up Experience

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Obagi Medical (“Obagi”), a leader in advanced skincare innovation, the originator of medical-grade skincare and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), has partnered with the world&...

WALD - Obagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin*

NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- Obagi Medical (“Obagi”), a leader in advanced skincare innovation, the originator of medical-grade skincare and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today announced the launch ...

WALD - Waldencast announces conclusion of SEC investigation

LONDON, April 28, 2026 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“ Waldencast ” or the “ Company ”), a global multi-brand beauty and wellness platform, announced today that it was notified by the staff of the U.S. Securities and Exchange Commission (the ȁ...

WALD - Obagi Medical Introduces NU-GEN(TM) Cellular Renewal Serum Designed to Visibly Rewind Skin's Age and Restore Visible Youthfulness

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Obagi Medical (“Obagi”), a leader in advanced skincare innovation, the originator of medical-grade skincare and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), is proud to announce the la...

WALD - Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ(TM)

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today announced a collaboration with ProMD Health as part ...

WALD - Expected earnings - Waldencast plc

Waldencast plc (WALD) is expected to report $-0.11 for Q4 2025

Next 10